Skip to main content
. 2022 Jan 9;77(5):1048–1054. doi: 10.1093/gerona/glac006

Table 3.

Odds Ratios (ORs) of Prevalent Frailty by NSAID Category, Stratified by Age, Major Comorbidities, and Aspirin Use

Variable Model* OR of Frailty vs Nonfrail 95% CI p-Interaction
Age
<75
N = 8 942
≤12 days/year 1.18 0.98–1.43 .51
13–60 days/year 1.65 1.35–2.02
>60 days/year 3.12 2.49–3.91
≥75
N = 3 159
≤12 days/year 1.21 1.00–1.47
13–60 days/year 1.69 1.36–2.10
>60 days/year 2.57 1.99–3.33
Coronary heart disease
No
N = 10 112
≤12 days/year 1.00 0.86–1.17 .08
13–60 days/year 1.42 1.21–1.68
>60 days/year 2.66 2.20–3.21
Yes
N = 1 989
≤12 days/year 1.02 0.78–1.34
13–60 days/year 1.24 0.93–1.67
>60 days/year 1.68 1.22–2.32
Arthritis
No
N = 8 529
≤12 days/year 0.97 0.83–1.14 .20
13–60 days/year 1.12 0.92–1.36
>60 days/year 1.77 1.36–2.30
 Yes
N = 3 572
≤12 days/year 0.68 0.53–0.87
13–60 days/year 0.78 0.60–0.995
>60 days/year 1.08 0.83–1.40
Gastrointestinal bleeding
No
N = 10 602
≤12 days/year 1.01 0.88–1.16 .80
13–60 days/year 1.38 1.19–1.62
>60 days/year 2.49 2.09–2.98
Yes
N = 1 499
≤12 days/year 0.93 0.67–1.30
13–60 days/year 1.48 1.03–2.12
>60 days/year 2.53 1.68–3.82
Renal disease
No
N = 11 260
≤12 days/year 1.00 0.87–1.14 .08
13–60 days/year 1.40 1.20–1.62
>60 days/year 2.61 2.20–3.10
Yes
N = 841
≤12 days/year 1.09 0.73–1.64
13–60 days/year 1.41 0.90–2.19
>60 days/year 1.69 1.01–2.82
Average aspirin use
<90 days/year
N = 2358
≤12 days/year 0.84 0.65–1.10 .24
13–60 days/year 1.20 0.89–1.62
>60 days/year 1.94 1.38–2.73
≥90 days/year
N = 9743
≤12 days/year 1.07 0.92–1.24
13–60 days/year 1.49 1.27–1.75
>60 days/year 2.75 2.29–3.31
Pain**
No
N = 4136
≤12 days/year 0.97 0.76–1.17 .58
13–60 days/year 1.05 0.80–1.38
>60 days/year 1.85 1.27–2.70
Yes
N = 7965
≤12 days/year 0.91 0.77–1.07
13–60 days/year 1.26 1.06–1.50
>60 days/year 2.15 1.77–2.61

Notes: CI = confidence interval; NSAID = nonsteroidal anti-inflammatory drug.

*Reference = no NSAID use.

**Pain: migraine, headache, or arthritis.